Results 211 to 220 of about 21,036,455 (371)
A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner
Molecular Oncology, EarlyView.We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp +13 more
wiley +1 more source
Retracted: Hardware Loop Simulation of Distributed Embedded Integrated Circuits
Journal of Control Science and Engineering, 2023 Journal of Control Science and Engineering
doaj +1 more source
Feedforward Adaption to Control Processes in Chemical Engineering
, 1985 Roland Strietzel, H. Töpfer
openalex +1 more source
Molecular Oncology, EarlyView.C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald +18 more
wiley +1 more source
Retracted: Computer Teaching System Based on Internet of Things and Machine Learning
Journal of Control Science and Engineering, 2023 Journal of Control Science and Engineering
doaj +1 more source
News from the Noise Control Engineering Journal/May–June 1991 [PDF]
, 1991 Stanley L. Ehrlich
openalex +1 more source
Control of Management Systems: A Control Engineer's View [PDF]
Measurement and Control, 1980 openaire +2 more sources
Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma
Molecular Oncology, EarlyView.The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias +12 more
wiley +1 more source
Journal of Control Science and Engineering, 2023 Journal of Control Science and Engineering
doaj +1 more source